The Principles of Clinical Cytogenetics - Extra Materials - Springer

410 Rizwan Naeem
4. Nowell, P.C. and Hungerford, D.A. (1960) A minute chromosome in human granulocytic leukemia. Science 132, 1497.
5. Rowley, J.D. (1999) The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36(4)(Suppl. 7), 59–72.
6. Nowell, P.C., Rowley, J.D., and Knudson, A.G., Jr. (1998) Cancer genetics, cytogenetics—defining the enemy within.
Nature Med. 4, 1107–1111.
7. Jaffe, E.S., Harris, N.L., Stein, H., and Vardiman, J.W. (eds.) (2001) The World Health Organization Classification in
Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 3rd ed., Inernational Agency for
Research on Cancer (IARC) Press, Lyon, France.
8. Faderl, S., Talpaz, M., Estrov, Z., and Kantarjian, H.M. (1999) Chronic myelogenous leukemia: biology and therapy.
Ann. Intern. Med. 131, 207–219.
9. Young, J.L., Jr., Percy, C.L., Asire, A.J., et al. (1977) Cancer Incidence and Mortality in the United States, 1973–77.
National Cancer Institute Monograph.
10. Gunz, F.W. (1977) The epidemiology and genetics of the chronic leukaemias. Clin. Haematol. 6, 3–20.
11. Savage, D.G., Szydlo, R.M., and Goldman, J.M. (1997) Clinical features at diagnosis in 430 patients with chronic
myeloid leukaemia seen at a referral centre over a 16-year period. Br. J. Haematol. 96, 111–116.
12. Rowley, J.D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by
quinacrine fluorescence and Giemsa staining. Nature 243, 290–293.
13. Bartram, C R., de Klein, A., Hagemeijer, A., et al. (1983) Translocation of c-ab1 oncogene correlates with the presence
of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 306(5940), 277–280.
14. Melo, J.V. (1996) The diversity of BCR–ABL fusion proteins and their relationship to leukemia phenotype. Blood 88,
2375–2384.
15. Pane, F., Frigeri, F., Sindona, M., et al. (1996) Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific
molecular marker (BCR/ABL with C3/A2 junction). Blood 88, 2410–2414.
16. Saglio, G., Pane, F., Gottardi, E., et al. (1996) Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts
are expressed by chronic myelogenous leukemia patients at diagnosis. Blood 87, 1075–1080.
17. Mitelman, F. (1993). The cytogenetic scenario of chronic myeloid leukemia. Leukocyte Lymphoma. 11(Suppl. 1), 11–15.
18. Gordon, M.Y. and Goldman, J.M. (1996) Cellular and molecular mechanisms in chronic myeloid leukaemia: biology
and treatment. Br. J. Haematol. 95, 10–20.
19. Lee, D.S., Lee, Y.-S., Yun, Y.-S., et al. (2003) A study on the incidence of ABL gene deletion on derivative chromosome
9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with
disease progression. Genes Chromosomes Cancer 37, 291–299.
20. Rumpel, M., Friedrich, T., and Deninger, M.W.N. (2003) Imatinib normalizes bone marrow vascularity in patients with
chronic myeloid leukemia in first chronic phase. Blood 101(11), 4641–4643.
21. Deeg, H.J., Storb, R., Thomas, E.D., et al. (1985) Cyclosporine as prophylaxis for graft-versus-host disease: a randomized
study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65, 1325–1335.
22. Druker, B.J. and Lydon, N.B. (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for
chronic myelogenous leukemia. J. Clin. Invest. 105, 3–7.
23. Mortazavi, Y., Tooze, J.A., Gordon-Smith, E.C., and Rutherford, T.R. (2000) N-RAS gene mutation in patients with
aplastic anemia and aplastic anemia/paroxysmal nocturnal hemoglobinuria during evolution to clonal disease. Blood
95, 646–650.
24. Froberg, M.K. and Brunning, R.D. (1998) Demonstration of clonality in in neutrophils using FISH in a case of chronic
neutrophilic leukemia. Leukemia 12, 623–626.
25. Yanagisawa, K., Ohminami, H., Sato, M., et al. (1998) Neoplastic involvement of granulocytic lineage, not granulocytic–monocytic,
monocytic, or erythrocytic lineage, in a ptient with chronic neurophilic leukemia. Am. J. Hematol. 57,
221–224.
26. DiDonato, C., Croci, G., Lazzari, S., Scarduelli, L., Vignoli, R., Buia, M., Tramaloni, C., Maccari, S., and Plancher,
A.C. (1986) Chronic neutrophilic leukemia: description of a new case with karyotypic abnormalities. Am. J. Clin.
Pathol. 85, 369–371.
27. Matano, S., Nakamura, S., Kobayashi, K., Yoshida, T., Matsuda, T., and Sugimoto, T. (1997) Monomorphic agranular
natural killer cell lymphoma/leukemia with no Epstein–Barr virus association. Am. J. Hematol. 54, 72–75.
28. Berkowicz, M., Rosner, E., Rechavi, G., et al. (1991) Atypical chronic myelomonocytic leukemia with eosinophilia and
translocation (5;12). A new association. Cancer Genet. and Cytogenet. 51, 277–278.
29. Golub, T.R., Barker, G.F., Lovett, M., and Gilliland, D.G. (1994) Fusion of PDGF receptor beta to a novel ets-like
gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307–316.
30. Baranger, L., Szapiro, N., Gardais, J., et al. (1994) Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation
associated with a myeloid disorder with eosinophilia. Br. J. Haematol. 88(2), 343–347.
31. Dewald, G.W. and Wright, P.I. (1995) Chromosome abnormalities in the myeloproliferative disorders. Semin. Oncol.
22, 341–354.
32. Rege-Cambrin, G., Mecucci, C., Tricot, G., et al. (1987) A chromosomal profile of polycythemia vera. Cancer Genet.
and Cytogenet. 25, 233–245.